INDIANAPOLIS, April 1, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that Axiron® (testosterone) topical solution is available in pharmacies throughout the United States.

INDIANAPOLIS, June 28, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced that a pivotal Phase III Axiron study, published on the Clinical Endocrinology website, showed that Axiron® ...

INDIANAPOLIS, IN and MELBOURNE, AUSTRALIA -- Eli Lilly and Company (NYSE:LLY) and Acrux (ASX: ACR) announced that the U.S. Food and Drug Administration (FDA) has approved Axiron® (testosterone) ...

INDIANAPOLIS — A topical medication for treating low testosterone in men now is available, drug maker Eli Lilly said. Lilly announced the availability of Axiron (testosterone), a topical solution ...

INDIANAPOLIS — A topical drug made by Eli Lilly restored testosterone to normal levels in men with abnormally low testosterone, according to results of a late-stage clinical trial. Lilly announced ...

AXIRON NDA currently under review by U.S. FDA for the treatment of testosterone deficiency in men INDIANAPOLIS and MELBOURNE, Australia, March 15, 2010 /PRNewswire via COMTEX News Network/ -- Eli ...

The new campaign for Lilly’s low testosterone treatment, Axiron, is a classic in both form and execution. The 60-second TV ad is highly targeted and assumptive—it does not explain the condition or how ...

ALLEGAN, Mich. (AP) -- Perrigo Co. said Wednesday it is seeking approval for a generic version of Eli Lilly and Co.'s Axiron testosterone product, and is being sued by Lilly. Axiron is an underarm gel ...

Treating men who have androgen deficiency with a 2% testosterone solution helped improve their sex drive and energy for at least 9 months without adding adverse effects, researchers say. Results from ...

First came the drug company ads aimed at older men. Feeling tired, irritable, lost your sex drive? Try our testosterone product. Then came the response ads from trial lawyers. Suffered a heart attack ...

Nearly six months after an advisory panel to the Food & Drug Administration voted overwhelmingly in favor of revising the labels on testosterone drugs, the agency has followed through with a stark ...

Makers of testosterone drugs must change the products’ labels to clarify that they are approved for only certain disorders, not to help men deal with aging, U.S. regulators said. Uses listed for the ...